The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3175-3179

  Merrill, Gary F ^a   Dowell, Paul ^a   Pearson, George D ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; THIOREDOXIN REDUCTASE;

ARTICLE; DNA BINDING; ENZYME ACTIVATION; GENE ACTIVATION; GENETIC TRANSCRIPTION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REPORTER GENE; TRANSACTIVATION; YEAST;

BETA-GALACTOSIDASE; GENES, P53; GENES, REPORTER; HUMANS; PLASMIDS; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SACCHAROMYCES CEREVISIAE; THIOREDOXIN REDUCTASE (NADPH); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0033168514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 1 arrest. Cell, 76: 1013-1023, 1994.
2. Unger, T., Nau, M. M., Segal, S., and Minna, J. D. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. Embo J., 11: 1383-1390, 1992.
3. Scolnick, D. M., Chehab, N. H., Stavridi, E. S., Lien, M. C., Caruso, L., Moran, E., Berger, S. L., and Halazonetis, T. D. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res., 57: 3693-3696, 1997.
4. Pavletich, N. P., Chambers, K. A., and Pabo, C. O. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev., 7: 2556-2564, 1993.
5. Sturzbecher, H. W., Brain, R., Addison, C., Rudge, K., Remm, M., Grimaldi, M., Keenan, E., and Jenkins, J. R. A C-terminal α-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene, 7: 1513-1523, 1992.
6. McLure, K. G., and Lee, P. W. How p53 binds DNA as a tetramer. Embo J., 17: 3342-3350, 1998.
7. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53. Cell, 71: 875-886, 1992.
8. Gu, W., and Roeder, R. G. Activation of p53 sequence-specific DNA binding by acelylation of the p53 C-terminal domain. Cell, 90: 595-606, 1997.
9. Hainaut, P., and Milner, J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res., 53: 1739-1742, 1993.
10. Guilhot, C., Jander, G., Martin, N. L., and Beckwith, J. Evidence that the pathway of disulfide bond formation in Escherichia coli involves interactions between the cysteines of DsbB and DsbA. Proc. Natl. Acad. Sci. USA, 92: 9895-9899, 1995.
11. Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11: 558-570, 1997.
12. Parks, D., Bolinger, R., and Mann, K. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res., 25: 1289-1295, 1997.
13. Wu, H. H., and Momand, J. Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J. Biol. Chem., 273: 18898-18905, 1998.
14. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y. C., and Curran, T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. Embo J., 11: 3323-3335, 1992.
15. Casso, D., and Beach, D. A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet., 252: 518-529, 1996.
16. Pearson, G. D., and Merrill, G. F. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression. J. Biol. Chem., 273; 5431-5434, 1998.
17. Wallis, J. W., Chrebet, G., Brodsky, G., Rolfe, M., and Rothstein, R. A hyperrecombination mutation in S. cerevisiae identifies a novel eucaryotic topoisomerase. Cell, 58: 409-419, 1989.
18. Le Douarin, B., Pierrat, B., vom Baur, E., Chambon, P., and Losson, R. A new version of the two-hybrid assay for detection of protein-protein interactions. Nucleic Acids Res., 23: 876-878, 1995.
19. Thiagalingam, S., Kinzler, K. W., and Vogelstein, B. PAK1, a gene that can regulate p53 activity in yeast. Proc. Natl. Acad. Sci. USA, 92: 6062-6066, 1995.
20. Sikorski, R., and Hieter, P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics, 122: 19-27, 1989.
21. Rainwater, R., Parks, D., Anderson, M. E., Tegtmeyer, P., and Mann, K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol., 15: 3892-3903, 1995.
22. Verhaegh, G. W., Richard, M-J., and Hainaut, P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell. Biol., 17: 5699-5706, 1997.
23. Hainaut, P., and Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53: 4469-4473, 1993.
24. Bakalkin, G., Selivanova, G., Yakovleva, T., Kiseleva, E., Kashuba, E., Magnusson, K. P., Szekely, L., Klein, G., Terenius, L., and Wiman, K. G. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res., 23: 362-369, 1995.
25. Hupp, T. R., Sparks, A., and Lane, D. P. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell, 83: 237-245, 1995.
26. Hansen, S., Midgley, C. A., Lane, D. P., Freeman, B. C., Morimoto, R. I., and Hupp, T. R. Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70. J. Biol. Chem., 271: 30922-30928, 1996.
27. Meek, D. W., Simon, S., Kikkawa, U., and Eckhart, W. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. Embo J., 9: 3253-3260, 1990.
28. Mundt, M., Hupp, T., Fritsche, M., Merkle, C., Hansen, S., Lane, D., and Groner, B. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene, 15: 237-244, 1997.